Queries around the viability of cell, gene and tissue engineering technologies have been mostly put to rest, now the focus is on how best to harness the huge potential these therapies offer.
The Alliance for Regenerative Medicines (ARM) was founded in 2009 with just 25 members. Its goal is to foster the...